Coincidentally, it has been indicated that anti-human TNFα Ab (infliximab) increased the iTreg frequency and enhanced their suppressor activity, and remained nTreg defective in RA patients and RA mouse model on human TNF-a transgenic mice35,36. This evidence concerns the gene TNF and rheumatoid arthritis.